nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinacalcet—CYP3A4—prostate cancer	0.202	1	CbGaD
Cinacalcet—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0532	0.113	CbGbCtD
Cinacalcet—CYP1A2—Flutamide—prostate cancer	0.0442	0.0936	CbGbCtD
Cinacalcet—CYP2D6—Bicalutamide—prostate cancer	0.0439	0.0931	CbGbCtD
Cinacalcet—CYP2D6—Abiraterone—prostate cancer	0.0364	0.0772	CbGbCtD
Cinacalcet—CYP1A2—Estrone—prostate cancer	0.0319	0.0677	CbGbCtD
Cinacalcet—CYP3A4—Bicalutamide—prostate cancer	0.0279	0.0592	CbGbCtD
Cinacalcet—CYP3A4—Estramustine—prostate cancer	0.026	0.055	CbGbCtD
Cinacalcet—CYP3A4—Abiraterone—prostate cancer	0.0231	0.0491	CbGbCtD
Cinacalcet—CYP3A4—Flutamide—prostate cancer	0.0231	0.0491	CbGbCtD
Cinacalcet—CYP1A2—Conjugated Estrogens—prostate cancer	0.0209	0.0443	CbGbCtD
Cinacalcet—CYP1A2—Estradiol—prostate cancer	0.0183	0.0389	CbGbCtD
Cinacalcet—CYP3A4—Cabazitaxel—prostate cancer	0.0171	0.0363	CbGbCtD
Cinacalcet—CYP3A4—Estrone—prostate cancer	0.0167	0.0355	CbGbCtD
Cinacalcet—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0149	0.0316	CbGbCtD
Cinacalcet—CYP1A2—Etoposide—prostate cancer	0.012	0.0254	CbGbCtD
Cinacalcet—CYP3A4—Conjugated Estrogens—prostate cancer	0.0109	0.0232	CbGbCtD
Cinacalcet—CYP3A4—Mitoxantrone—prostate cancer	0.00995	0.0211	CbGbCtD
Cinacalcet—CYP3A4—Estradiol—prostate cancer	0.00961	0.0204	CbGbCtD
Cinacalcet—CYP3A4—Prednisone—prostate cancer	0.00826	0.0175	CbGbCtD
Cinacalcet—CYP2D6—Doxorubicin—prostate cancer	0.00673	0.0143	CbGbCtD
Cinacalcet—CYP3A4—Etoposide—prostate cancer	0.00627	0.0133	CbGbCtD
Cinacalcet—CYP3A4—Docetaxel—prostate cancer	0.00574	0.0122	CbGbCtD
Cinacalcet—CYP3A4—Doxorubicin—prostate cancer	0.00428	0.00907	CbGbCtD
Cinacalcet—CASR—renal system—prostate cancer	0.00336	0.385	CbGeAlD
Cinacalcet—CYP1A2—urine—prostate cancer	0.0017	0.196	CbGeAlD
Cinacalcet—CYP3A4—urine—prostate cancer	0.00123	0.142	CbGeAlD
Cinacalcet—CYP2D6—urine—prostate cancer	0.00121	0.139	CbGeAlD
Cinacalcet—Tipranavir—CYP2C19—prostate cancer	0.000851	0.207	CrCbGaD
Cinacalcet—Tipranavir—CYP3A4—prostate cancer	0.000541	0.132	CrCbGaD
Cinacalcet—Dexfenfluramine—CYP2A6—prostate cancer	0.000502	0.122	CrCbGaD
Cinacalcet—CYP1A2—renal system—prostate cancer	0.000417	0.0478	CbGeAlD
Cinacalcet—Dexfenfluramine—CYP2E1—prostate cancer	0.000357	0.0869	CrCbGaD
Cinacalcet—Dexfenfluramine—CYP2C19—prostate cancer	0.000353	0.0861	CrCbGaD
Cinacalcet—Floctafenine—PTGS2—prostate cancer	0.000327	0.0797	CrCbGaD
Cinacalcet—CYP3A4—renal system—prostate cancer	0.000302	0.0346	CbGeAlD
Cinacalcet—CYP2D6—renal system—prostate cancer	0.000297	0.0341	CbGeAlD
Cinacalcet—Fluoxetine—CYP3A5—prostate cancer	0.000273	0.0664	CrCbGaD
Cinacalcet—CYP2D6—testis—prostate cancer	0.000192	0.022	CbGeAlD
Cinacalcet—Fluoxetine—CYP2C19—prostate cancer	0.000186	0.0452	CrCbGaD
Cinacalcet—Propranolol—CYP3A5—prostate cancer	0.000166	0.0405	CrCbGaD
Cinacalcet—Propranolol—ADRB2—prostate cancer	0.000132	0.0321	CrCbGaD
Cinacalcet—Constipation—Mitoxantrone—prostate cancer	0.000119	0.000594	CcSEcCtD
Cinacalcet—Rash—Goserelin—prostate cancer	0.000119	0.000593	CcSEcCtD
Cinacalcet—Dermatitis—Goserelin—prostate cancer	0.000119	0.000593	CcSEcCtD
Cinacalcet—Vomiting—Conjugated Estrogens—prostate cancer	0.000119	0.000593	CcSEcCtD
Cinacalcet—Urticaria—Estradiol—prostate cancer	0.000119	0.000593	CcSEcCtD
Cinacalcet—Immune system disorder—Capecitabine—prostate cancer	0.000119	0.000592	CcSEcCtD
Cinacalcet—Abdominal pain—Estradiol—prostate cancer	0.000118	0.00059	CcSEcCtD
Cinacalcet—Body temperature increased—Estradiol—prostate cancer	0.000118	0.00059	CcSEcCtD
Cinacalcet—Headache—Goserelin—prostate cancer	0.000118	0.00059	CcSEcCtD
Cinacalcet—Malnutrition—Docetaxel—prostate cancer	0.000118	0.000589	CcSEcCtD
Cinacalcet—Fluoxetine—CYP3A4—prostate cancer	0.000118	0.0288	CrCbGaD
Cinacalcet—Rash—Conjugated Estrogens—prostate cancer	0.000118	0.000588	CcSEcCtD
Cinacalcet—Dermatitis—Conjugated Estrogens—prostate cancer	0.000118	0.000587	CcSEcCtD
Cinacalcet—Arrhythmia—Capecitabine—prostate cancer	0.000117	0.000585	CcSEcCtD
Cinacalcet—Headache—Conjugated Estrogens—prostate cancer	0.000117	0.000584	CcSEcCtD
Cinacalcet—Infection—Etoposide—prostate cancer	0.000115	0.000574	CcSEcCtD
Cinacalcet—Malnutrition—Capecitabine—prostate cancer	0.000114	0.00057	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000114	0.000568	CcSEcCtD
Cinacalcet—Dehydration—Doxorubicin—prostate cancer	0.000114	0.000567	CcSEcCtD
Cinacalcet—Muscle spasms—Docetaxel—prostate cancer	0.000114	0.000566	CcSEcCtD
Cinacalcet—Propranolol—CYP2C19—prostate cancer	0.000113	0.0276	CrCbGaD
Cinacalcet—Propranolol—CYP1A1—prostate cancer	0.000113	0.0275	CrCbGaD
Cinacalcet—Skin disorder—Etoposide—prostate cancer	0.000113	0.000562	CcSEcCtD
Cinacalcet—Nausea—Goserelin—prostate cancer	0.000112	0.000559	CcSEcCtD
Cinacalcet—Nausea—Conjugated Estrogens—prostate cancer	0.000111	0.000554	CcSEcCtD
Cinacalcet—Urticaria—Mitoxantrone—prostate cancer	0.000111	0.000552	CcSEcCtD
Cinacalcet—Anorexia—Etoposide—prostate cancer	0.000111	0.000551	CcSEcCtD
Cinacalcet—Hypersensitivity—Estradiol—prostate cancer	0.00011	0.00055	CcSEcCtD
Cinacalcet—Abdominal pain—Mitoxantrone—prostate cancer	0.00011	0.00055	CcSEcCtD
Cinacalcet—Body temperature increased—Mitoxantrone—prostate cancer	0.00011	0.00055	CcSEcCtD
Cinacalcet—Muscle spasms—Capecitabine—prostate cancer	0.00011	0.000548	CcSEcCtD
Cinacalcet—Anaemia—Docetaxel—prostate cancer	0.000109	0.000544	CcSEcCtD
Cinacalcet—Hypotension—Etoposide—prostate cancer	0.000108	0.00054	CcSEcCtD
Cinacalcet—Asthenia—Estradiol—prostate cancer	0.000107	0.000535	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000106	0.00053	CcSEcCtD
Cinacalcet—Pruritus—Estradiol—prostate cancer	0.000106	0.000528	CcSEcCtD
Cinacalcet—Anaemia—Capecitabine—prostate cancer	0.000106	0.000527	CcSEcCtD
Cinacalcet—Immune system disorder—Prednisone—prostate cancer	0.000106	0.000527	CcSEcCtD
Cinacalcet—Arrhythmia—Prednisone—prostate cancer	0.000105	0.000521	CcSEcCtD
Cinacalcet—Paraesthesia—Etoposide—prostate cancer	0.000104	0.000519	CcSEcCtD
Cinacalcet—Dyspnoea—Etoposide—prostate cancer	0.000103	0.000516	CcSEcCtD
Cinacalcet—Cough—Docetaxel—prostate cancer	0.000103	0.000514	CcSEcCtD
Cinacalcet—Hypersensitivity—Mitoxantrone—prostate cancer	0.000103	0.000512	CcSEcCtD
Cinacalcet—Diarrhoea—Estradiol—prostate cancer	0.000102	0.00051	CcSEcCtD
Cinacalcet—Convulsion—Docetaxel—prostate cancer	0.000102	0.00051	CcSEcCtD
Cinacalcet—Hypertension—Docetaxel—prostate cancer	0.000102	0.000508	CcSEcCtD
Cinacalcet—Malnutrition—Prednisone—prostate cancer	0.000102	0.000508	CcSEcCtD
Cinacalcet—Decreased appetite—Etoposide—prostate cancer	0.000101	0.000503	CcSEcCtD
Cinacalcet—Chest pain—Docetaxel—prostate cancer	0.000101	0.000501	CcSEcCtD
Cinacalcet—Myalgia—Docetaxel—prostate cancer	0.000101	0.000501	CcSEcCtD
Cinacalcet—Arthralgia—Docetaxel—prostate cancer	0.000101	0.000501	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Etoposide—prostate cancer	0.0001	0.000499	CcSEcCtD
Cinacalcet—Asthenia—Mitoxantrone—prostate cancer	0.0001	0.000499	CcSEcCtD
Cinacalcet—Fatigue—Etoposide—prostate cancer	0.0001	0.000499	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	9.98e-05	0.000498	CcSEcCtD
Cinacalcet—Cough—Capecitabine—prostate cancer	9.98e-05	0.000497	CcSEcCtD
Cinacalcet—Constipation—Etoposide—prostate cancer	9.92e-05	0.000494	CcSEcCtD
Cinacalcet—Dizziness—Estradiol—prostate cancer	9.89e-05	0.000493	CcSEcCtD
Cinacalcet—Hypertension—Capecitabine—prostate cancer	9.87e-05	0.000492	CcSEcCtD
Cinacalcet—Upper respiratory tract infection—Doxorubicin—prostate cancer	9.83e-05	0.00049	CcSEcCtD
Cinacalcet—Chest pain—Capecitabine—prostate cancer	9.73e-05	0.000485	CcSEcCtD
Cinacalcet—Arthralgia—Capecitabine—prostate cancer	9.73e-05	0.000485	CcSEcCtD
Cinacalcet—Myalgia—Capecitabine—prostate cancer	9.73e-05	0.000485	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	9.67e-05	0.000482	CcSEcCtD
Cinacalcet—Infection—Docetaxel—prostate cancer	9.57e-05	0.000477	CcSEcCtD
Cinacalcet—Diarrhoea—Mitoxantrone—prostate cancer	9.54e-05	0.000476	CcSEcCtD
Cinacalcet—Vomiting—Estradiol—prostate cancer	9.51e-05	0.000474	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Etoposide—prostate cancer	9.48e-05	0.000473	CcSEcCtD
Cinacalcet—Nervous system disorder—Docetaxel—prostate cancer	9.45e-05	0.000471	CcSEcCtD
Cinacalcet—Rash—Estradiol—prostate cancer	9.43e-05	0.00047	CcSEcCtD
Cinacalcet—Dermatitis—Estradiol—prostate cancer	9.42e-05	0.00047	CcSEcCtD
Cinacalcet—Anaemia—Prednisone—prostate cancer	9.41e-05	0.000469	CcSEcCtD
Cinacalcet—Headache—Estradiol—prostate cancer	9.37e-05	0.000467	CcSEcCtD
Cinacalcet—Skin disorder—Docetaxel—prostate cancer	9.36e-05	0.000467	CcSEcCtD
Cinacalcet—Angioedema—Prednisone—prostate cancer	9.3e-05	0.000464	CcSEcCtD
Cinacalcet—Infection—Capecitabine—prostate cancer	9.27e-05	0.000462	CcSEcCtD
Cinacalcet—Urticaria—Etoposide—prostate cancer	9.21e-05	0.000459	CcSEcCtD
Cinacalcet—Anorexia—Docetaxel—prostate cancer	9.19e-05	0.000458	CcSEcCtD
Cinacalcet—Abdominal pain—Etoposide—prostate cancer	9.17e-05	0.000457	CcSEcCtD
Cinacalcet—Body temperature increased—Etoposide—prostate cancer	9.17e-05	0.000457	CcSEcCtD
Cinacalcet—Nervous system disorder—Capecitabine—prostate cancer	9.15e-05	0.000456	CcSEcCtD
Cinacalcet—Skin disorder—Capecitabine—prostate cancer	9.06e-05	0.000452	CcSEcCtD
Cinacalcet—Oedema peripheral—Epirubicin—prostate cancer	9.01e-05	0.000449	CcSEcCtD
Cinacalcet—Hypotension—Docetaxel—prostate cancer	9e-05	0.000449	CcSEcCtD
Cinacalcet—Anorexia—Capecitabine—prostate cancer	8.89e-05	0.000443	CcSEcCtD
Cinacalcet—Nausea—Estradiol—prostate cancer	8.89e-05	0.000443	CcSEcCtD
Cinacalcet—Vomiting—Mitoxantrone—prostate cancer	8.86e-05	0.000442	CcSEcCtD
Cinacalcet—Convulsion—Prednisone—prostate cancer	8.82e-05	0.00044	CcSEcCtD
Cinacalcet—Hypertension—Prednisone—prostate cancer	8.79e-05	0.000438	CcSEcCtD
Cinacalcet—Rash—Mitoxantrone—prostate cancer	8.79e-05	0.000438	CcSEcCtD
Cinacalcet—Dermatitis—Mitoxantrone—prostate cancer	8.78e-05	0.000438	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.78e-05	0.000438	CcSEcCtD
Cinacalcet—Headache—Mitoxantrone—prostate cancer	8.73e-05	0.000435	CcSEcCtD
Cinacalcet—Hypotension—Capecitabine—prostate cancer	8.72e-05	0.000435	CcSEcCtD
Cinacalcet—Myalgia—Prednisone—prostate cancer	8.67e-05	0.000432	CcSEcCtD
Cinacalcet—Arthralgia—Prednisone—prostate cancer	8.67e-05	0.000432	CcSEcCtD
Cinacalcet—Paraesthesia—Docetaxel—prostate cancer	8.65e-05	0.000432	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.61e-05	0.000429	CcSEcCtD
Cinacalcet—Dyspnoea—Docetaxel—prostate cancer	8.59e-05	0.000428	CcSEcCtD
Cinacalcet—Hypersensitivity—Etoposide—prostate cancer	8.54e-05	0.000426	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.5e-05	0.000424	CcSEcCtD
Cinacalcet—Dyspepsia—Docetaxel—prostate cancer	8.48e-05	0.000423	CcSEcCtD
Cinacalcet—Paraesthesia—Capecitabine—prostate cancer	8.38e-05	0.000418	CcSEcCtD
Cinacalcet—Decreased appetite—Docetaxel—prostate cancer	8.38e-05	0.000418	CcSEcCtD
Cinacalcet—Oedema peripheral—Doxorubicin—prostate cancer	8.34e-05	0.000416	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Docetaxel—prostate cancer	8.32e-05	0.000415	CcSEcCtD
Cinacalcet—Asthenia—Etoposide—prostate cancer	8.32e-05	0.000415	CcSEcCtD
Cinacalcet—Dyspnoea—Capecitabine—prostate cancer	8.32e-05	0.000415	CcSEcCtD
Cinacalcet—Fatigue—Docetaxel—prostate cancer	8.31e-05	0.000414	CcSEcCtD
Cinacalcet—Nausea—Mitoxantrone—prostate cancer	8.28e-05	0.000413	CcSEcCtD
Cinacalcet—Immune system disorder—Epirubicin—prostate cancer	8.26e-05	0.000412	CcSEcCtD
Cinacalcet—Infection—Prednisone—prostate cancer	8.26e-05	0.000412	CcSEcCtD
Cinacalcet—Constipation—Docetaxel—prostate cancer	8.24e-05	0.000411	CcSEcCtD
Cinacalcet—Dyspepsia—Capecitabine—prostate cancer	8.21e-05	0.00041	CcSEcCtD
Cinacalcet—Pruritus—Etoposide—prostate cancer	8.2e-05	0.000409	CcSEcCtD
Cinacalcet—Arrhythmia—Epirubicin—prostate cancer	8.17e-05	0.000408	CcSEcCtD
Cinacalcet—Nervous system disorder—Prednisone—prostate cancer	8.15e-05	0.000406	CcSEcCtD
Cinacalcet—Decreased appetite—Capecitabine—prostate cancer	8.11e-05	0.000404	CcSEcCtD
Cinacalcet—Skin disorder—Prednisone—prostate cancer	8.07e-05	0.000403	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Capecitabine—prostate cancer	8.06e-05	0.000402	CcSEcCtD
Cinacalcet—Fatigue—Capecitabine—prostate cancer	8.04e-05	0.000401	CcSEcCtD
Cinacalcet—Constipation—Capecitabine—prostate cancer	7.98e-05	0.000398	CcSEcCtD
Cinacalcet—Malnutrition—Epirubicin—prostate cancer	7.96e-05	0.000397	CcSEcCtD
Cinacalcet—Diarrhoea—Etoposide—prostate cancer	7.93e-05	0.000396	CcSEcCtD
Cinacalcet—Anorexia—Prednisone—prostate cancer	7.92e-05	0.000395	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Docetaxel—prostate cancer	7.88e-05	0.000393	CcSEcCtD
Cinacalcet—Dizziness—Etoposide—prostate cancer	7.67e-05	0.000382	CcSEcCtD
Cinacalcet—Muscle spasms—Epirubicin—prostate cancer	7.66e-05	0.000382	CcSEcCtD
Cinacalcet—Immune system disorder—Doxorubicin—prostate cancer	7.65e-05	0.000381	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Capecitabine—prostate cancer	7.63e-05	0.00038	CcSEcCtD
Cinacalcet—Abdominal pain—Docetaxel—prostate cancer	7.62e-05	0.00038	CcSEcCtD
Cinacalcet—Body temperature increased—Docetaxel—prostate cancer	7.62e-05	0.00038	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Prednisone—prostate cancer	7.57e-05	0.000378	CcSEcCtD
Cinacalcet—Arrhythmia—Doxorubicin—prostate cancer	7.56e-05	0.000377	CcSEcCtD
Cinacalcet—Paraesthesia—Prednisone—prostate cancer	7.46e-05	0.000372	CcSEcCtD
Cinacalcet—Urticaria—Capecitabine—prostate cancer	7.41e-05	0.00037	CcSEcCtD
Cinacalcet—Body temperature increased—Capecitabine—prostate cancer	7.38e-05	0.000368	CcSEcCtD
Cinacalcet—Abdominal pain—Capecitabine—prostate cancer	7.38e-05	0.000368	CcSEcCtD
Cinacalcet—Vomiting—Etoposide—prostate cancer	7.37e-05	0.000368	CcSEcCtD
Cinacalcet—Malnutrition—Doxorubicin—prostate cancer	7.37e-05	0.000367	CcSEcCtD
Cinacalcet—Anaemia—Epirubicin—prostate cancer	7.36e-05	0.000367	CcSEcCtD
Cinacalcet—Dyspepsia—Prednisone—prostate cancer	7.32e-05	0.000365	CcSEcCtD
Cinacalcet—Rash—Etoposide—prostate cancer	7.31e-05	0.000365	CcSEcCtD
Cinacalcet—Dermatitis—Etoposide—prostate cancer	7.3e-05	0.000364	CcSEcCtD
Cinacalcet—Headache—Etoposide—prostate cancer	7.26e-05	0.000362	CcSEcCtD
Cinacalcet—Decreased appetite—Prednisone—prostate cancer	7.22e-05	0.00036	CcSEcCtD
Cinacalcet—Propranolol—CYP3A4—prostate cancer	7.2e-05	0.0175	CrCbGaD
Cinacalcet—Fatigue—Prednisone—prostate cancer	7.17e-05	0.000357	CcSEcCtD
Cinacalcet—Constipation—Prednisone—prostate cancer	7.11e-05	0.000354	CcSEcCtD
Cinacalcet—Hypersensitivity—Docetaxel—prostate cancer	7.1e-05	0.000354	CcSEcCtD
Cinacalcet—Muscle spasms—Doxorubicin—prostate cancer	7.09e-05	0.000353	CcSEcCtD
Cinacalcet—Cough—Epirubicin—prostate cancer	6.95e-05	0.000347	CcSEcCtD
Cinacalcet—Asthenia—Docetaxel—prostate cancer	6.91e-05	0.000345	CcSEcCtD
Cinacalcet—Convulsion—Epirubicin—prostate cancer	6.9e-05	0.000344	CcSEcCtD
Cinacalcet—Nausea—Etoposide—prostate cancer	6.89e-05	0.000343	CcSEcCtD
Cinacalcet—Hypertension—Epirubicin—prostate cancer	6.88e-05	0.000343	CcSEcCtD
Cinacalcet—Hypersensitivity—Capecitabine—prostate cancer	6.87e-05	0.000343	CcSEcCtD
Cinacalcet—Pruritus—Docetaxel—prostate cancer	6.82e-05	0.00034	CcSEcCtD
Cinacalcet—Anaemia—Doxorubicin—prostate cancer	6.81e-05	0.00034	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Prednisone—prostate cancer	6.8e-05	0.000339	CcSEcCtD
Cinacalcet—Myalgia—Epirubicin—prostate cancer	6.78e-05	0.000338	CcSEcCtD
Cinacalcet—Arthralgia—Epirubicin—prostate cancer	6.78e-05	0.000338	CcSEcCtD
Cinacalcet—Chest pain—Epirubicin—prostate cancer	6.78e-05	0.000338	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.73e-05	0.000336	CcSEcCtD
Cinacalcet—Asthenia—Capecitabine—prostate cancer	6.69e-05	0.000334	CcSEcCtD
Cinacalcet—Urticaria—Prednisone—prostate cancer	6.6e-05	0.000329	CcSEcCtD
Cinacalcet—Pruritus—Capecitabine—prostate cancer	6.6e-05	0.000329	CcSEcCtD
Cinacalcet—Diarrhoea—Docetaxel—prostate cancer	6.59e-05	0.000329	CcSEcCtD
Cinacalcet—Abdominal pain—Prednisone—prostate cancer	6.57e-05	0.000328	CcSEcCtD
Cinacalcet—Body temperature increased—Prednisone—prostate cancer	6.57e-05	0.000328	CcSEcCtD
Cinacalcet—Infection—Epirubicin—prostate cancer	6.46e-05	0.000322	CcSEcCtD
Cinacalcet—Cough—Doxorubicin—prostate cancer	6.43e-05	0.000321	CcSEcCtD
Cinacalcet—Convulsion—Doxorubicin—prostate cancer	6.38e-05	0.000318	CcSEcCtD
Cinacalcet—Diarrhoea—Capecitabine—prostate cancer	6.38e-05	0.000318	CcSEcCtD
Cinacalcet—Nervous system disorder—Epirubicin—prostate cancer	6.37e-05	0.000318	CcSEcCtD
Cinacalcet—Dizziness—Docetaxel—prostate cancer	6.37e-05	0.000318	CcSEcCtD
Cinacalcet—Hypertension—Doxorubicin—prostate cancer	6.36e-05	0.000317	CcSEcCtD
Cinacalcet—Skin disorder—Epirubicin—prostate cancer	6.31e-05	0.000315	CcSEcCtD
Cinacalcet—Chest pain—Doxorubicin—prostate cancer	6.27e-05	0.000313	CcSEcCtD
Cinacalcet—Myalgia—Doxorubicin—prostate cancer	6.27e-05	0.000313	CcSEcCtD
Cinacalcet—Arthralgia—Doxorubicin—prostate cancer	6.27e-05	0.000313	CcSEcCtD
Cinacalcet—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.23e-05	0.000311	CcSEcCtD
Cinacalcet—Anorexia—Epirubicin—prostate cancer	6.2e-05	0.000309	CcSEcCtD
Cinacalcet—Dizziness—Capecitabine—prostate cancer	6.17e-05	0.000308	CcSEcCtD
Cinacalcet—Vomiting—Docetaxel—prostate cancer	6.13e-05	0.000306	CcSEcCtD
Cinacalcet—Hypersensitivity—Prednisone—prostate cancer	6.12e-05	0.000305	CcSEcCtD
Cinacalcet—Rash—Docetaxel—prostate cancer	6.08e-05	0.000303	CcSEcCtD
Cinacalcet—Hypotension—Epirubicin—prostate cancer	6.07e-05	0.000303	CcSEcCtD
Cinacalcet—Dermatitis—Docetaxel—prostate cancer	6.07e-05	0.000303	CcSEcCtD
Cinacalcet—Headache—Docetaxel—prostate cancer	6.04e-05	0.000301	CcSEcCtD
Cinacalcet—Infection—Doxorubicin—prostate cancer	5.98e-05	0.000298	CcSEcCtD
Cinacalcet—Asthenia—Prednisone—prostate cancer	5.96e-05	0.000297	CcSEcCtD
Cinacalcet—Vomiting—Capecitabine—prostate cancer	5.93e-05	0.000296	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.92e-05	0.000295	CcSEcCtD
Cinacalcet—Nervous system disorder—Doxorubicin—prostate cancer	5.9e-05	0.000294	CcSEcCtD
Cinacalcet—Rash—Capecitabine—prostate cancer	5.88e-05	0.000293	CcSEcCtD
Cinacalcet—Pruritus—Prednisone—prostate cancer	5.88e-05	0.000293	CcSEcCtD
Cinacalcet—Dermatitis—Capecitabine—prostate cancer	5.88e-05	0.000293	CcSEcCtD
Cinacalcet—Headache—Capecitabine—prostate cancer	5.85e-05	0.000291	CcSEcCtD
Cinacalcet—Skin disorder—Doxorubicin—prostate cancer	5.84e-05	0.000291	CcSEcCtD
Cinacalcet—Paraesthesia—Epirubicin—prostate cancer	5.84e-05	0.000291	CcSEcCtD
Cinacalcet—Dyspnoea—Epirubicin—prostate cancer	5.8e-05	0.000289	CcSEcCtD
Cinacalcet—Anorexia—Doxorubicin—prostate cancer	5.73e-05	0.000286	CcSEcCtD
Cinacalcet—Nausea—Docetaxel—prostate cancer	5.72e-05	0.000285	CcSEcCtD
Cinacalcet—Dyspepsia—Epirubicin—prostate cancer	5.72e-05	0.000285	CcSEcCtD
Cinacalcet—Diarrhoea—Prednisone—prostate cancer	5.69e-05	0.000284	CcSEcCtD
Cinacalcet—Decreased appetite—Epirubicin—prostate cancer	5.65e-05	0.000282	CcSEcCtD
Cinacalcet—Hypotension—Doxorubicin—prostate cancer	5.62e-05	0.00028	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Epirubicin—prostate cancer	5.61e-05	0.00028	CcSEcCtD
Cinacalcet—Fatigue—Epirubicin—prostate cancer	5.6e-05	0.000279	CcSEcCtD
Cinacalcet—Constipation—Epirubicin—prostate cancer	5.56e-05	0.000277	CcSEcCtD
Cinacalcet—Nausea—Capecitabine—prostate cancer	5.54e-05	0.000276	CcSEcCtD
Cinacalcet—Dizziness—Prednisone—prostate cancer	5.5e-05	0.000274	CcSEcCtD
Cinacalcet—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.48e-05	0.000273	CcSEcCtD
Cinacalcet—Paraesthesia—Doxorubicin—prostate cancer	5.4e-05	0.000269	CcSEcCtD
Cinacalcet—Dyspnoea—Doxorubicin—prostate cancer	5.36e-05	0.000267	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Epirubicin—prostate cancer	5.32e-05	0.000265	CcSEcCtD
Cinacalcet—Dyspepsia—Doxorubicin—prostate cancer	5.29e-05	0.000264	CcSEcCtD
Cinacalcet—Vomiting—Prednisone—prostate cancer	5.28e-05	0.000264	CcSEcCtD
Cinacalcet—Rash—Prednisone—prostate cancer	5.24e-05	0.000261	CcSEcCtD
Cinacalcet—Dermatitis—Prednisone—prostate cancer	5.24e-05	0.000261	CcSEcCtD
Cinacalcet—Decreased appetite—Doxorubicin—prostate cancer	5.23e-05	0.000261	CcSEcCtD
Cinacalcet—Headache—Prednisone—prostate cancer	5.21e-05	0.00026	CcSEcCtD
Cinacalcet—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.19e-05	0.000259	CcSEcCtD
Cinacalcet—Fatigue—Doxorubicin—prostate cancer	5.19e-05	0.000259	CcSEcCtD
Cinacalcet—Urticaria—Epirubicin—prostate cancer	5.16e-05	0.000257	CcSEcCtD
Cinacalcet—Constipation—Doxorubicin—prostate cancer	5.14e-05	0.000256	CcSEcCtD
Cinacalcet—Abdominal pain—Epirubicin—prostate cancer	5.14e-05	0.000256	CcSEcCtD
Cinacalcet—Body temperature increased—Epirubicin—prostate cancer	5.14e-05	0.000256	CcSEcCtD
Cinacalcet—Nausea—Prednisone—prostate cancer	4.94e-05	0.000246	CcSEcCtD
Cinacalcet—Gastrointestinal pain—Doxorubicin—prostate cancer	4.92e-05	0.000245	CcSEcCtD
Cinacalcet—Hypersensitivity—Epirubicin—prostate cancer	4.79e-05	0.000239	CcSEcCtD
Cinacalcet—Urticaria—Doxorubicin—prostate cancer	4.78e-05	0.000238	CcSEcCtD
Cinacalcet—Abdominal pain—Doxorubicin—prostate cancer	4.75e-05	0.000237	CcSEcCtD
Cinacalcet—Body temperature increased—Doxorubicin—prostate cancer	4.75e-05	0.000237	CcSEcCtD
Cinacalcet—Asthenia—Epirubicin—prostate cancer	4.66e-05	0.000233	CcSEcCtD
Cinacalcet—Pruritus—Epirubicin—prostate cancer	4.6e-05	0.000229	CcSEcCtD
Cinacalcet—Diarrhoea—Epirubicin—prostate cancer	4.45e-05	0.000222	CcSEcCtD
Cinacalcet—Hypersensitivity—Doxorubicin—prostate cancer	4.43e-05	0.000221	CcSEcCtD
Cinacalcet—Asthenia—Doxorubicin—prostate cancer	4.32e-05	0.000215	CcSEcCtD
Cinacalcet—Dizziness—Epirubicin—prostate cancer	4.3e-05	0.000214	CcSEcCtD
Cinacalcet—Pruritus—Doxorubicin—prostate cancer	4.26e-05	0.000212	CcSEcCtD
Cinacalcet—Vomiting—Epirubicin—prostate cancer	4.13e-05	0.000206	CcSEcCtD
Cinacalcet—Diarrhoea—Doxorubicin—prostate cancer	4.12e-05	0.000205	CcSEcCtD
Cinacalcet—Rash—Epirubicin—prostate cancer	4.1e-05	0.000204	CcSEcCtD
Cinacalcet—Dermatitis—Epirubicin—prostate cancer	4.09e-05	0.000204	CcSEcCtD
Cinacalcet—Headache—Epirubicin—prostate cancer	4.07e-05	0.000203	CcSEcCtD
Cinacalcet—Dizziness—Doxorubicin—prostate cancer	3.98e-05	0.000198	CcSEcCtD
Cinacalcet—Nausea—Epirubicin—prostate cancer	3.86e-05	0.000193	CcSEcCtD
Cinacalcet—Vomiting—Doxorubicin—prostate cancer	3.82e-05	0.000191	CcSEcCtD
Cinacalcet—Rash—Doxorubicin—prostate cancer	3.79e-05	0.000189	CcSEcCtD
Cinacalcet—Dermatitis—Doxorubicin—prostate cancer	3.79e-05	0.000189	CcSEcCtD
Cinacalcet—Headache—Doxorubicin—prostate cancer	3.77e-05	0.000188	CcSEcCtD
Cinacalcet—Nausea—Doxorubicin—prostate cancer	3.57e-05	0.000178	CcSEcCtD
Cinacalcet—CYP3A4—Metabolism—PGAM2—prostate cancer	1.23e-05	0.000108	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NAGLU—prostate cancer	1.23e-05	0.000108	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.23e-05	0.000108	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTM3—prostate cancer	1.23e-05	0.000108	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—RFK—prostate cancer	1.23e-05	0.000108	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—LDHB—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TNFRSF21—prostate cancer	1.2e-05	0.000106	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP3A5—prostate cancer	1.19e-05	0.000105	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTAP—prostate cancer	1.17e-05	0.000104	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP7B1—prostate cancer	1.17e-05	0.000104	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.16e-05	0.000103	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AMACR—prostate cancer	1.16e-05	0.000103	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.16e-05	0.000103	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—DEGS1—prostate cancer	1.16e-05	0.000103	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NAT1—prostate cancer	1.16e-05	0.000103	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTA3—prostate cancer	1.15e-05	0.000101	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TCN2—prostate cancer	1.15e-05	0.000101	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PDHA1—prostate cancer	1.15e-05	0.000101	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—UCP3—prostate cancer	1.15e-05	0.000101	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SULT1E1—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SRD5A1—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.11e-05	9.8e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.11e-05	9.8e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC22A3—prostate cancer	1.09e-05	9.66e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HSD3B1—prostate cancer	1.09e-05	9.66e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.09e-05	9.66e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ACSL4—prostate cancer	1.09e-05	9.63e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HSD17B3—prostate cancer	1.09e-05	9.63e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.08e-05	9.52e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TBXAS1—prostate cancer	1.05e-05	9.26e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTA4—prostate cancer	1.05e-05	9.26e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PHGDH—prostate cancer	1.04e-05	9.23e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ARG2—prostate cancer	1.04e-05	9.23e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—UMPS—prostate cancer	1.04e-05	9.23e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.04e-05	9.18e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—LDHB—prostate cancer	1.02e-05	9.05e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTA2—prostate cancer	1.02e-05	9.03e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SULT1A1—prostate cancer	1.01e-05	8.92e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ABCG5—prostate cancer	1.01e-05	8.92e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP3A5—prostate cancer	1e-05	8.89e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HPGD—prostate cancer	9.88e-06	8.74e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—B4GALT4—prostate cancer	9.88e-06	8.74e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTA1—prostate cancer	9.85e-06	8.71e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HSD3B2—prostate cancer	9.74e-06	8.61e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTO1—prostate cancer	9.74e-06	8.61e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NAT2—prostate cancer	9.74e-06	8.61e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TCN2—prostate cancer	9.7e-06	8.58e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTA3—prostate cancer	9.7e-06	8.58e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PDHA1—prostate cancer	9.7e-06	8.58e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—UCP3—prostate cancer	9.7e-06	8.58e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PLCB2—prostate cancer	9.34e-06	8.26e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—LRP2—prostate cancer	9.34e-06	8.26e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP2C18—prostate cancer	9.34e-06	8.26e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TNFRSF21—prostate cancer	9.29e-06	8.22e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HSD3B1—prostate cancer	9.26e-06	8.19e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC22A3—prostate cancer	9.26e-06	8.19e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—P4HB—prostate cancer	9.16e-06	8.1e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTAP—prostate cancer	9.04e-06	7.99e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP7B1—prostate cancer	9.04e-06	7.99e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	8.98e-06	7.94e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC22A1—prostate cancer	8.91e-06	7.88e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTA4—prostate cancer	8.88e-06	7.85e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TBXAS1—prostate cancer	8.88e-06	7.85e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SULT1E1—prostate cancer	8.81e-06	7.79e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SRD5A1—prostate cancer	8.81e-06	7.79e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SULT2A1—prostate cancer	8.68e-06	7.68e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	8.67e-06	7.67e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTA2—prostate cancer	8.65e-06	7.65e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SULT1A1—prostate cancer	8.54e-06	7.55e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ABCG5—prostate cancer	8.54e-06	7.55e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MED12—prostate cancer	8.54e-06	7.55e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GNG5—prostate cancer	8.47e-06	7.49e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ACSL4—prostate cancer	8.4e-06	7.43e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HSD17B3—prostate cancer	8.4e-06	7.43e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTA1—prostate cancer	8.34e-06	7.38e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NAT2—prostate cancer	8.25e-06	7.3e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HSD3B2—prostate cancer	8.25e-06	7.3e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTO1—prostate cancer	8.25e-06	7.3e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NCOA3—prostate cancer	8.16e-06	7.22e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—UMPS—prostate cancer	8.06e-06	7.12e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ARG2—prostate cancer	8.06e-06	7.12e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PHGDH—prostate cancer	8.06e-06	7.12e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.93e-06	7.02e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PLCB2—prostate cancer	7.91e-06	7e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—LRP2—prostate cancer	7.91e-06	7e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP2C18—prostate cancer	7.91e-06	7e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—LDHB—prostate cancer	7.9e-06	6.99e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—HPGDS—prostate cancer	7.79e-06	6.89e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—P4HB—prostate cancer	7.76e-06	6.86e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP3A5—prostate cancer	7.75e-06	6.86e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP2C19—prostate cancer	7.74e-06	6.84e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ACHE—prostate cancer	7.55e-06	6.68e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTT1—prostate cancer	7.55e-06	6.68e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC22A1—prostate cancer	7.55e-06	6.67e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TCN2—prostate cancer	7.49e-06	6.62e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PDHA1—prostate cancer	7.49e-06	6.62e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTA3—prostate cancer	7.49e-06	6.62e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—UCP3—prostate cancer	7.49e-06	6.62e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP2A6—prostate cancer	7.46e-06	6.6e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.46e-06	6.6e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SULT2A1—prostate cancer	7.35e-06	6.5e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKR1C3—prostate cancer	7.26e-06	6.42e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MED12—prostate cancer	7.23e-06	6.4e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PRKACB—prostate cancer	7.22e-06	6.39e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GNG5—prostate cancer	7.18e-06	6.35e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP17A1—prostate cancer	7.15e-06	6.32e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC22A3—prostate cancer	7.14e-06	6.32e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HSD3B1—prostate cancer	7.14e-06	6.32e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NCOA3—prostate cancer	6.91e-06	6.11e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TBXAS1—prostate cancer	6.85e-06	6.06e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTA4—prostate cancer	6.85e-06	6.06e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NCOA2—prostate cancer	6.81e-06	6.02e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.79e-06	6.01e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTA2—prostate cancer	6.67e-06	5.9e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—HPGDS—prostate cancer	6.6e-06	5.83e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ABCG5—prostate cancer	6.59e-06	5.83e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SULT1A1—prostate cancer	6.59e-06	5.83e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP2C19—prostate cancer	6.55e-06	5.8e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—SLC5A5—prostate cancer	6.5e-06	5.75e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTA1—prostate cancer	6.44e-06	5.69e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTT1—prostate cancer	6.4e-06	5.66e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ACHE—prostate cancer	6.4e-06	5.66e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTO1—prostate cancer	6.37e-06	5.63e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HSD3B2—prostate cancer	6.37e-06	5.63e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NAT2—prostate cancer	6.37e-06	5.63e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP2E1—prostate cancer	6.35e-06	5.61e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP2A6—prostate cancer	6.32e-06	5.59e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.3e-06	5.57e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NQO1—prostate cancer	6.28e-06	5.55e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TH—prostate cancer	6.19e-06	5.47e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKR1C3—prostate cancer	6.15e-06	5.44e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP3A4—prostate cancer	6.12e-06	5.41e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PRKACB—prostate cancer	6.12e-06	5.41e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PLCB2—prostate cancer	6.1e-06	5.4e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—LRP2—prostate cancer	6.1e-06	5.4e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP2C18—prostate cancer	6.1e-06	5.4e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP17A1—prostate cancer	6.06e-06	5.36e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP1B1—prostate cancer	6.02e-06	5.32e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—P4HB—prostate cancer	5.99e-06	5.29e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.97e-06	5.28e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GGT1—prostate cancer	5.83e-06	5.15e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.82e-06	5.15e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NCOA2—prostate cancer	5.77e-06	5.1e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NCOA1—prostate cancer	5.74e-06	5.08e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SULT2A1—prostate cancer	5.68e-06	5.02e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP19A1—prostate cancer	5.66e-06	5e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MED12—prostate cancer	5.58e-06	4.94e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GNG5—prostate cancer	5.54e-06	4.9e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—SLC5A5—prostate cancer	5.51e-06	4.87e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—RXRA—prostate cancer	5.46e-06	4.83e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP2E1—prostate cancer	5.38e-06	4.76e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NCOA3—prostate cancer	5.34e-06	4.72e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NQO1—prostate cancer	5.32e-06	4.7e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—COMT—prostate cancer	5.26e-06	4.65e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TH—prostate cancer	5.24e-06	4.63e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTP1—prostate cancer	5.23e-06	4.63e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.21e-06	4.6e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP3A4—prostate cancer	5.18e-06	4.59e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.16e-06	4.56e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ITPR1—prostate cancer	5.15e-06	4.55e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP1B1—prostate cancer	5.1e-06	4.51e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—HPGDS—prostate cancer	5.09e-06	4.5e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP2C19—prostate cancer	5.06e-06	4.47e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTT1—prostate cancer	4.94e-06	4.37e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ACHE—prostate cancer	4.94e-06	4.37e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GGT1—prostate cancer	4.94e-06	4.37e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.88e-06	4.32e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—TYMS—prostate cancer	4.87e-06	4.3e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NCOA1—prostate cancer	4.86e-06	4.3e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—GSTM1—prostate cancer	4.81e-06	4.25e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP19A1—prostate cancer	4.79e-06	4.24e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.75e-06	4.2e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PRKACB—prostate cancer	4.72e-06	4.18e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—LPL—prostate cancer	4.72e-06	4.18e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.67e-06	4.13e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—RXRA—prostate cancer	4.63e-06	4.09e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CYP1A1—prostate cancer	4.56e-06	4.03e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—ERCC2—prostate cancer	4.52e-06	4e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.5e-06	3.98e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—COMT—prostate cancer	4.46e-06	3.94e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NCOA2—prostate cancer	4.45e-06	3.94e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTP1—prostate cancer	4.43e-06	3.92e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ITPR1—prostate cancer	4.36e-06	3.86e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.29e-06	3.79e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—MTHFR—prostate cancer	4.25e-06	3.76e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—SLC5A5—prostate cancer	4.25e-06	3.76e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PPARA—prostate cancer	4.17e-06	3.69e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP2E1—prostate cancer	4.15e-06	3.67e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—TYMS—prostate cancer	4.12e-06	3.65e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NQO1—prostate cancer	4.1e-06	3.63e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—GSTM1—prostate cancer	4.08e-06	3.6e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TH—prostate cancer	4.04e-06	3.58e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—LPL—prostate cancer	4e-06	3.54e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.93e-06	3.48e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CAV1—prostate cancer	3.92e-06	3.47e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.86e-06	3.42e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—ERCC2—prostate cancer	3.83e-06	3.39e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GGT1—prostate cancer	3.81e-06	3.37e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NCOA1—prostate cancer	3.75e-06	3.32e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.7e-06	3.27e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—MTHFR—prostate cancer	3.6e-06	3.18e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CG—prostate cancer	3.57e-06	3.16e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—RXRA—prostate cancer	3.57e-06	3.16e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PPARA—prostate cancer	3.53e-06	3.12e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—COMT—prostate cancer	3.44e-06	3.04e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTP1—prostate cancer	3.42e-06	3.03e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—INS—prostate cancer	3.38e-06	2.99e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ITPR1—prostate cancer	3.37e-06	2.98e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CAV1—prostate cancer	3.32e-06	2.94e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—CREBBP—prostate cancer	3.31e-06	2.93e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—TYMS—prostate cancer	3.18e-06	2.81e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.17e-06	2.81e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—GSTM1—prostate cancer	3.14e-06	2.78e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CD—prostate cancer	3.14e-06	2.78e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—LPL—prostate cancer	3.09e-06	2.73e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CG—prostate cancer	3.03e-06	2.68e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.98e-06	2.64e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—NOS3—prostate cancer	2.97e-06	2.62e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—ERCC2—prostate cancer	2.96e-06	2.61e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—INS—prostate cancer	2.86e-06	2.53e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—CREBBP—prostate cancer	2.81e-06	2.48e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—MTHFR—prostate cancer	2.78e-06	2.46e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.74e-06	2.42e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PPARA—prostate cancer	2.73e-06	2.41e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTGS2—prostate cancer	2.71e-06	2.4e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.66e-06	2.35e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CAV1—prostate cancer	2.56e-06	2.27e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—NOS3—prostate cancer	2.51e-06	2.22e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PTEN—prostate cancer	2.36e-06	2.09e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.34e-06	2.07e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CB—prostate cancer	2.32e-06	2.05e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTGS2—prostate cancer	2.3e-06	2.03e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—EP300—prostate cancer	2.26e-06	1.99e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—INS—prostate cancer	2.21e-06	1.95e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—CREBBP—prostate cancer	2.17e-06	1.91e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.05e-06	1.82e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PTEN—prostate cancer	2e-06	1.77e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—NOS3—prostate cancer	1.94e-06	1.71e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—EP300—prostate cancer	1.91e-06	1.69e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.79e-06	1.58e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTGS2—prostate cancer	1.77e-06	1.57e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.67e-06	1.48e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PTEN—prostate cancer	1.55e-06	1.37e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—EP300—prostate cancer	1.47e-06	1.3e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.41e-06	1.25e-05	CbGpPWpGaD
Cinacalcet—CYP2D6—Metabolism—AKT1—prostate cancer	1.36e-06	1.21e-05	CbGpPWpGaD
Cinacalcet—CYP1A2—Metabolism—AKT1—prostate cancer	1.15e-06	1.02e-05	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.09e-06	9.65e-06	CbGpPWpGaD
Cinacalcet—CYP3A4—Metabolism—AKT1—prostate cancer	8.91e-07	7.88e-06	CbGpPWpGaD
